薬効薬理 | 製品情報 | エナロイ.jp｜鳥居薬品株式会社
押さえておきたい新薬情報】腎性貧血治療薬（HIF-PH阻害薬）マスーレッド錠 | 医療従事者・介護従事者”必見”の医療情報ポータルサイト｜EM-AVALON
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD - ScienceDirect
APExBIO - DMOG|Competitive HIF-PH inhibitor, cell-permeable|CAS# 89464-63-1
HIF PH Inhibitors for Anemia in CKD: A Physiologic Approach | PPT
HIF-PH阻害薬 5種類の特徴まとめ - 臨床工学技士の熱血透析blog
SEC Filing | FibroGen, Inc.
Edgar V. Lerma 🇵🇭 on X: "Anemia in CKD: Role of HIF & HIF-PH in erythropoiesis from @Medscape @MedscapeKidney https://t.co/dEaj6E299d https://t.co/K1HPD9NRgL" / X
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
IJMS | Free Full-Text | Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?”
Treatment of anemia in difficult-to-manage patients with chronic kidney disease - Kidney International Supplements
腎性貧血を治療するHIF-PH阻害薬 | 千船病院【大阪市西淀川区】
DMOG
Molecules | Free Full-Text | The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
The roles of HIF-1α signaling in cardiovascular diseases - ScienceDirect
HIF-PH阻害薬 | me
A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
L'inhibiteur HIF-PH de GlaxoSmithKline Duvroq (daprodustat) a reçu la première approbation mondiale au Japon! - Connaissance - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
Daprodustat
Oxygen biology in the CKD patients
新しい貧血改善薬、HIF－PH阻害薬について - 東都三軒茶屋クリニック 東京都 世田谷区 内科 透析 夜間透析
Hif ph inhibitors for anemia in ckd | PPT
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects | Clinical and Experimental Nephrology
作用機序｜マスーレッド｜腎領域の総合情報サイト Renal CONNECT
a, b HIF activity under normoxic/ hypoxic conditions and HIF-PHI... | Download Scientific Diagram
